Analyst Conference Summaries

Biotechnology Investor Aids

Bind Therapeutics
BIND

conference date: May 9, 2016 @ 5:30 AM Pacific Time

Sold My BIND on July 5, 2016. no further coverage expected

Bind Therapeutics Makes Deal to Pay Down Loan [May 19, 2016]

Surprise: Bind Therapeutics Seeks Bankruptcy Protection [May 2, 2016]

I'm Accumulating Bind Therapeutics At These Levels [April 8, 2016 @ Seeking Alpha]

2016
05/09/2016
2015
05/07/2015
08/06/2015
11/02/2015
03/15/2016

Bind Therapeutics (BIND) is a developer and manufacturer of therapies called accurins.

BIND web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 BIND
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 HNSN
 INO
 INTC
 ISRG
 JUNO
 MACK
 MCHP
 MDVN
 MYL.
 NVDA
 OPXA
 PLX
 REGN
 SGEN
 XLNX
 XLRN

 

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but it is possible. This is investment journalism, not financial advice.

Copyright 2015 William P. Meyers